Open Letter: Requesting Clarification on the Recent Deal on Generic Bedaquiline Supply

Partners In Health Press Release 1 August 2023 Mr. Joaquin DuatoChief Executive OfficerJohnson & JohnsonOne Johnson & Johnson PlazaNew Brunswick, NJ 08933USA cc: Ms. Anna Carvaggio, Managing Director & Vice President, Johnson & Johnson;Dr. Brenda Waning, Chief, Global Drug Facility, Stop TB Partnership Open letter: Requesting clarification on the recent Read more…